Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,092 | -24,333 | -98,942 | -77,655 | -55,706 |
| Depreciation Amortization | 3,927 | 2,006 | 7,648 | 5,670 | 3,763 |
| Accounts receivable | -1,604 | -6,667 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,645 | -2,474 | -353 | 106 | -1,537 |
| Other Working Capital | -18,275 | -12,666 | 11,799 | -16,422 | -9,064 |
| Other Operating Activity | 8,508 | 11,741 | 16,994 | 12,781 | 10,107 |
| Operating Cash Flow | $-44,181 | $-32,393 | $-62,854 | $-75,520 | $-52,437 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -647 | -306 | -1,937 | -2,133 | -1,655 |
| Purchase Of Investment | 0 | 0 | -21,832 | -21,832 | -15,456 |
| Sale Of Investment | 0 | 0 | 136,087 | 118,887 | 91,495 |
| Investing Cash Flow | $-647 | $-306 | $112,318 | $94,922 | $74,384 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61,239 | 480 | 465 | 419 | 122 |
| Common Stock Repurchased | N/A | N/A | -197 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -196 | -197 |
| Financing Cash Flow | $61,239 | $480 | $268 | $223 | $-75 |
| Beginning Cash Position | 85,933 | 85,933 | 36,201 | 37,601 | 37,601 |
| End Cash Position | 102,344 | 53,714 | 85,933 | 57,226 | 59,473 |
| Net Cash Flow | $16,411 | $-32,219 | $49,732 | $19,625 | $21,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,181 | -32,393 | -62,854 | -75,520 | -52,437 |
| Capital Expenditure | -647 | -306 | -1,937 | -2,133 | -1,655 |
| Free Cash Flow | -44,828 | -32,699 | -64,791 | -77,653 | -54,092 |